Trial Outcomes & Findings for Caring for the Radial Artery Post-angiogram (NCT NCT01326455)

NCT ID: NCT01326455

Last Updated: 2022-09-28

Results Overview

Number of Participants with Bleeding Requiring Intervention after initial hemostasis achieved

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

75 participants

Primary outcome timeframe

Assessed after initial hemostasis achieved

Results posted on

2022-09-28

Participant Flow

The pilot study was set in one Cardiac Cath Lab and Recovery room. The sample was one of convenience. The goal was for 75 people to participate, 25 per group. The individuals targeted were those having an angiogram done on a non-emergent, outpatient basis. Recruitment took place from May 2009 until March 2010.

Participants were enrolled prior to the angiogram. Those patients in whom the transradial approach was initiated but aborted due to inability to puncture the radial artery were not included in the study. Enrolled patients were also excluded if the angiogram was performed solely via the femoral artery.

Participant milestones

Participant milestones
Measure
Terumo Control
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 1 hour after final deflation.
Terumo Fast Release
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 1 hour after final deflation.
Clo-Sur P.A.D.
A hydrophilic dressing with a high affinity for water and absorbs and controls body fluid that was removed on post-CATH day 1
Overall Study
STARTED
25
25
25
Overall Study
COMPLETED
15
20
18
Overall Study
NOT COMPLETED
10
5
7

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Caring for the Radial Artery Post-angiogram

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Terumo Control
n=25 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 1 hour after final deflation
Terumo Fast Release
n=25 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 15 minutes after final deflation.
Clo-Sur P.A.D.
n=25 Participants
A hydrophilic dressing with a high affinity for water and absorbs and controls body fluid that was removed on post-CATH day 1
Total
n=75 Participants
Total of all reporting groups
Age, Continuous
63.4 years
STANDARD_DEVIATION 11.2 • n=99 Participants
62.1 years
STANDARD_DEVIATION 8.3 • n=107 Participants
64.1 years
STANDARD_DEVIATION 10.6 • n=206 Participants
63.2 years
STANDARD_DEVIATION 10 • n=7 Participants
Age, Customized
>=18 years
25 participants
n=99 Participants
25 participants
n=107 Participants
25 participants
n=206 Participants
75 participants
n=7 Participants
Sex: Female, Male
Female
4 Participants
n=99 Participants
4 Participants
n=107 Participants
3 Participants
n=206 Participants
11 Participants
n=7 Participants
Sex: Female, Male
Male
21 Participants
n=99 Participants
21 Participants
n=107 Participants
22 Participants
n=206 Participants
64 Participants
n=7 Participants
Region of Enrollment
Canada
25 participants
n=99 Participants
25 participants
n=107 Participants
25 participants
n=206 Participants
75 participants
n=7 Participants

PRIMARY outcome

Timeframe: Assessed after initial hemostasis achieved

Number of Participants with Bleeding Requiring Intervention after initial hemostasis achieved

Outcome measures

Outcome measures
Measure
Terumo Control
n=25 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 1 hour after final deflation.
Terumo Fast Release
n=25 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 15 minutes after final deflation.
Clo-Sur P.A.D.
n=25 Participants
A hydrophilic dressing with a high affinity for water and absorbs and controls body fluid that was removed on post-CATH day 1
Bleeding Requiring Intervention After Initial Hemostasis Achieved
2 participants
6 participants
3 participants

PRIMARY outcome

Timeframe: Assessed post-CATH Day 1

Population: Lancaster et. al. (2004) quoted the number 30 as a general sample size for a pilot study. Each arm of this study had 25 people (due to time constraints), giving a total of 75 people. The data were analyzed using t-tests for equality of means, a two-way analysis of variance (ANOVA), and chi-square. Significance was set at p \< 0.05.

Number of Participants with Bleeding Requiring Intervention post-CATH Day 1

Outcome measures

Outcome measures
Measure
Terumo Control
n=15 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 1 hour after final deflation.
Terumo Fast Release
n=20 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 15 minutes after final deflation.
Clo-Sur P.A.D.
n=18 Participants
A hydrophilic dressing with a high affinity for water and absorbs and controls body fluid that was removed on post-CATH day 1
Bleeding Requiring Intervention Post-CATH Day 1
0 participants
1 participants
0 participants

SECONDARY outcome

Timeframe: Assessed on day of angiogram.

Time to discharge in minutes.

Outcome measures

Outcome measures
Measure
Terumo Control
n=25 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 1 hour after final deflation.
Terumo Fast Release
n=25 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 15 minutes after final deflation.
Clo-Sur P.A.D.
n=25 Participants
A hydrophilic dressing with a high affinity for water and absorbs and controls body fluid that was removed on post-CATH day 1
Time to Discharge
178.2 minutes
Standard Deviation 50.4
134 minutes
Standard Deviation 45.8
113.7 minutes
Standard Deviation 48.0

SECONDARY outcome

Timeframe: Assessed at discharge

Number of Participants with hematoma or bruising at discharge

Outcome measures

Outcome measures
Measure
Terumo Control
n=25 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 1 hour after final deflation.
Terumo Fast Release
n=25 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 15 minutes after final deflation.
Clo-Sur P.A.D.
n=25 Participants
A hydrophilic dressing with a high affinity for water and absorbs and controls body fluid that was removed on post-CATH day 1
Hematoma or Bruising at Discharge
1 participants
2 participants
0 participants

SECONDARY outcome

Timeframe: Assessed post-CATH day 1.

Number of Participants with hematoma or bruising post-CATH Day 1

Outcome measures

Outcome measures
Measure
Terumo Control
n=14 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 1 hour after final deflation.
Terumo Fast Release
n=18 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 15 minutes after final deflation.
Clo-Sur P.A.D.
n=17 Participants
A hydrophilic dressing with a high affinity for water and absorbs and controls body fluid that was removed on post-CATH day 1
Hematoma or Bruising Post-CATH Day 1
4 participants
4 participants
7 participants

SECONDARY outcome

Timeframe: Assessed via plethysmography and palpation post-CATH

Number of Participants with Radial Artery Occlusion post-CATH

Outcome measures

Outcome measures
Measure
Terumo Control
n=25 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 1 hour after final deflation.
Terumo Fast Release
n=25 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 15 minutes after final deflation.
Clo-Sur P.A.D.
n=25 Participants
A hydrophilic dressing with a high affinity for water and absorbs and controls body fluid that was removed on post-CATH day 1
Radial Artery Occlusion Post-CATH
0 participants
0 participants
0 participants

SECONDARY outcome

Timeframe: Assessed via plethysmography and palpation post-CATH day 1.

Number of Participants with Radial Artery Occlusion post-CATH Day 1

Outcome measures

Outcome measures
Measure
Terumo Control
n=15 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 1 hour after final deflation.
Terumo Fast Release
n=20 Participants
A transparent unilateral compression device secured to the wrist via strap with velcro that was removed 15 minutes after final deflation.
Clo-Sur P.A.D.
n=18 Participants
A hydrophilic dressing with a high affinity for water and absorbs and controls body fluid that was removed on post-CATH day 1
Radial Artery Occlusion Post-CATH Day 1
0 participants
0 participants
0 participants

Adverse Events

Terumo Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Terumo Fast Release

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Clo-Sur P.A.D.

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jennifer Fech

UAlberta

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place